Asian stock markets are trading mostly higher on Thursday, despite the broadly negative cues from Wall Street overnight, as the markets react to the US Fed's decision to lower interest rates for the ...
FedEx (NYSE: FDX) is scheduled to report its fiscal Q1 2025 results on Thursday, 9 (FedEx’s fiscal year ends in May). We expect the company to post an upbeat quarter, driven by an overall improvement ...
Intel stock (NASDAQ: INTC) rallied by close to 6% in Monday’s trading and gained by another 8% in after-hours trading, taking the stock to levels of about $22 per share. Intel stock still remains down ...
Elon Musk has indicated that the U.S. Federal Reserve’s tight monetary policy is a key factor behind Tesla’s cooling sales, particularly in the U.S. market. With financing costs elevated, many ...
(RTTNews) - Bel Fuse Inc. (BELFA, BELFB) announced that it agreed to acquire a majority stake in Enercon Technologies, Ltd. from Fortissimo Capital based on an enterprise value of $400 million. Bel ...
Benchmark indexes Sensex and Nifty gave up early gains to end modestly lower on Wednesday, after having hit new record highs in intraday trade. Asian markets traded mixed this morning, with sentiment ...
The project will employ five of Plug's 5 MW containerized PEM electrolyzers with a 25 MW capacity to decarbonize the operations at bp's Castellón refinery in Valencia, Spain and is expected to avoid ...
(RTTNews) - The Indonesia stock market on Wednesday ended the three-day winning streak in which it had advanced more than 80 points or 1 percent. The Jakarta Composite Index now rests just beneath the ...
The Australian market is slightly higher on Thursday, extending the gains in the previous five sessions, despite the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is ...
(RTTNews) - The China stock market on Wednesday ended the three-day losing streak in which it had stumbled more than 40 points or 1.5 percent. The Shanghai Composite now sits just above the ...
Incyte (INCY) and Syndax Pharmaceuticals (SNDX) announced that results from the pivotal Phase 2 AGAVE-201 trial of Niktimvo(axatilimab-csfr), an anti-CSF-1R antibody, in adult and pediatric patients ...
For nearly two decades, companies on the New York Stock Exchange (NYSE) have transferred their listings to Nasdaq. This year, Nasdaq is celebrating a major milestone, 500 listings have made the switch ...